Skip to main content

Pharmacy

By Susan Morse | 10:53 am | July 11, 2025
PBM provision, silver loading left out of final version of One Big Beautiful Bill Act due to Byrd Rule.
By Susan Morse | 11:00 am | July 08, 2025
Unless vacated, the directive will result in preventable deaths, including the unborn and newborns under six months old, lawsuit says.
By Susan Morse | 11:26 am | July 03, 2025
The policy would have prevented PBMs from having their compensation linked to the list price of medications.
By Jeff Lagasse | 10:33 am | July 03, 2025
The company is adding new products treating a range of issues, including HIV, hypertension and behavioral health.
By Jeff Lagasse | 11:17 am | June 30, 2025
Kennedy, criticized for anti-vaccination views, is accusing Gavi of "ignoring the science."
By Jeff Lagasse | 03:36 pm | June 24, 2025
Ninety-two percent of GLP-1 prescriptions could have been filled at a lower price, study finds.
By Susan Morse | 10:39 am | June 13, 2025
Kennedy named the new panel in a post on X on Wednesday, two days after firing all 17 ACIP members.
By Susan Morse | 11:16 am | June 11, 2025
Tax policy has shifted drug manufacturing to Switzerland, Ireland and Germany, says Johns Hopkins expert.
By Jeff Lagasse | 10:48 am | June 11, 2025
The pricing relationship is entirely between GoodRx and the pharmacy, with no involvement from a PBM.
By Susan Morse | 11:26 am | June 10, 2025
Committee members have conflicts of interest and have acted as a rubber stamp for vaccines, Kennedy wrote in a WSJ op-ed.